Human papillomavirus infection and HRAS, PIK3CA mutations analysis in patients with early laryngeal carcinoma

VernacularTitle:早期喉癌患者人乳头状瘤病毒感染与HRAS、PIK3CA突变分析
Author: Hongzhi WANG ; Rui SUN ; Weihan HU
Publication Type:Journal Article
Keywords: Laryngeal neoplasms; Human papillomavirus; p16; HRAS; PIK3CA; Prognosis
From: Cancer Research and Clinic 2014;26(6):361-365,372
CountryChina
Language:Chinese
Abstract: Objective To detect human papillomavirus (HPV) infection and HRAS,PIK3CA mutations in early laungeal squamous cell carcinoma (LSCC),and prognostic analysis regarding the clinicopathological teatures,including HPV status,was conducted.Methods A total of 186 patients with T2N0-1M0 LSCC were included in this study.HPV infection,p16INK4A expression,and PIK3CA,HRAS hot spot mutations were detected.Results 9.8 ％ (16/163) cases of high-risk HPV infection and 3.8 ％ (7/186) cases of p16INK4A overexpression were found in the cohort.Three cases of PIK3CA mutation and no HRAS mutation were found.HPV-positive cases had a significantly longer overall survival (OS) (P =0.019).N1 stage had a significantly reduced RFS (P =0.021).In multivariate analysis,HPV status was the only significantly prognostic factor for OS (RR =0.30,95 ％ CI 0.09-0.96,P =0.043).Conclusions p16 cannot be used as a surrogate biomarker of HPV status in early LSCC patients.HRAS or PIK3CA mutation is not a common event in early LSCC,and no mutation is found in HPV-positive cases.HPV status is an independent prognostic factor for survival.